Mutations Associated with No Durable Clinical Benefit to Immune Checkpoint Blockade in Non-S-Cell Lung Cancer

SIMPLE SUMMARY: With the application of immunotherapy in patients with non-small-cell lung cancer (NSCLC), we found that immunotherapy for some patients cannot achieve long-term effects. Therefore, the purpose of this study is to explore the characteristics of these patients and make a model that ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Guangsheng, Ren, Dian, Lei, Xi, Shi, Ruifeng, Zhu, Shuai, Zhou, Ning, Zu, Lingling, Mello, Ramon Andrade De, Chen, Jun, XU, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003499/
https://www.ncbi.nlm.nih.gov/pubmed/33808631
http://dx.doi.org/10.3390/cancers13061397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003499/
https://www.ncbi.nlm.nih.gov/pubmed/33808631
http://dx.doi.org/10.3390/cancers13061397

Ejemplares similares